This segment focuses on the research, development, and manufacturing of a wide range of pharmaceutical products, including chemicals, biochemicals, and Chinese medicines. R&D activities include the development of innovative drugs, with a focus on improving its ability in technological innovation. The company utilizes advanced manufacturing technologies to produce approximately 700 varieties of drugs across various therapeutic areas, including digestion, cardiovascular, anti-infection, nervous system, and oncology. The patient impact is significant, as these drugs address a broad spectrum of health conditions. Shanghai Pharmaceuticals aims to maintain its market position by investing in R&D and expanding its product portfolio. Future opportunities lie in the development of new drugs and expansion into new therapeutic areas. Regulatory compliance and clinical trials are crucial aspects of this segment, ensuring the safety and efficacy of the products. Partnerships and collaborations are essential for accessing new technologies and markets.

This segment provides pharmaceutical distribution, warehousing, logistics, and supply chain solutions to pharmaceutical manufacturers, hospitals, distributors, and retail pharmacies. The company leverages its extensive distribution network and logistics capabilities to ensure the efficient and timely delivery of healthcare products. This segment focuses on optimizing the supply chain to reduce costs and improve access to medicines. The company uses advanced logistics and warehousing technologies to manage its distribution network. The patient impact is improved access to medicines and healthcare products. Shanghai Pharmaceuticals aims to maintain its market leadership by expanding its distribution network and enhancing its supply chain capabilities. Future opportunities include expanding into new markets and offering value-added services. Regulatory compliance and adherence to quality standards are critical for this segment. Partnerships with manufacturers and healthcare providers are essential for success.

This segment involves the operation of a network of retail pharmacy stores and an online drug retail business. The company provides a wide range of pharmaceutical and healthcare products directly to consumers. The retail segment focuses on providing convenient access to medications and healthcare products. The company utilizes technology to enhance the customer experience, including online ordering and delivery services. The patient impact is improved access to medications and healthcare products. Shanghai Pharmaceuticals aims to expand its retail network and enhance its online presence. Future opportunities include expanding into new markets and offering value-added services. Regulatory compliance and adherence to quality standards are critical for this segment. Partnerships with pharmaceutical manufacturers and healthcare providers are essential for success.